BlackRock
CSCI

BlackRock’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

BlackRock’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-507
Closed -$26K – 5159
2020
Q1 		$26K Buy
507
+46
+10% +$4.2K ﹤0.01% 4581
2019
Q4 		$42K Sell
461
-5
-1% -$466 ﹤0.01% 4561
2019
Q3 		$48K Buy
466
+8
+2% +$1.73K ﹤0.01% 4545
2019
Q2 		$135K Buy
+458
New +$161K ﹤0.01% 4425
2019
Q1 		– Sell
-49
Closed -$14K – 5073
2018
Q4 		$14K Buy
+49
New +$11.7K ﹤0.01% 4625

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock's CSCI Position: Q2 2020 in Review

BlackRock sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2020, closing a stake of 507 shares — an estimated $26K sold.

BlackRock first reported a position in CSCI in Q4 2018 and held it in 5 quarters. The position peaked at $135K in Q2 2019. 17 funds tracked by Wall St. Rank hold CSCI as of Q2 2020.

  • BlackRock reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • BlackRock sold 507 COSCIENS Biopharma Inc. Common Stock shares in Q2 2020, an estimated $26K.
  • BlackRock first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2018 and held it in 5 quarters.
  • BlackRock's COSCIENS Biopharma Inc. Common Stock position peaked at $135K in Q2 2019.
  • 17 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2020.

Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.